Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001493152-25-026804
Filing Date
2025-12-09
Accepted
2025-12-09 11:24:52
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 14224
2 EX-4 ex4.htm EX-4 9085
  Complete submission text file 0001493152-25-026804.txt   24816
Mailing Address 85 MEDINAT HA-YEHUDIM STREET HERZLIYA L3 4676670
Business Address 85 MEDINAT HA-YEHUDIM STREET HERZLIYA L3 4676670 972774605012
Intercure Ltd. (Subject) CIK: 0001857030 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-93664 | Film No.: 251558048
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O, INTERCURE LTD. 85 MEDINAT HA-YEHUDIM STREET HERZLIYA Israel 4676670
Business Address
Rabinovich Alexander (Filed by) CIK: 0002081490 (see all company filings)

Type: SCHEDULE 13D